Presentation TCT 2012 The PC Trial: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Embolism Presenter: Stephan Windecker October 25, 2012
Presentation TCT 2012 RESPECT: A Prospective, Randomized Trial of PFO Closure vs. Medical Therapy in Patients with Cryptogenic Stroke Presenter: John Carroll October 25, 2012
Presentation TCT 2012 Outcomes of ASD Closure with a Deficient Rim Presenter: Frank Ing October 25, 2012
News Industry News St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke October 25, 2012
Presentation TCT 2012 Patient Selection for PFO Closure: Who Should Be Treated Always, Sometimes, and Never? Presenter: Jonathan Tobis October 25, 2012
Presentation TCT 2012 Has PFO Closure for Stroke Prevention Finally Gotten Enough RESPECT? Presenter: Jonathan Tobis October 25, 2012
News Industry News Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke October 25, 2012
News Industry News Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy October 25, 2012
Presentation TCT 2012 PFO Closure to Prevent Venous-to-Systemic Embolism: Intuitive Yes, but Where Are the Data? Presenter: Robert Sommer October 24, 2012
Presentation TCT 2012 TCT-85. Efficacy and Safety of Percutaneous Patent Foramen Ovale Closure in Patients with a Hypercoagulable Disorder Presenter: Ignacio Cruz-Gonz?lez October 23, 2012
Presentation TCT 2012 PFO Closure for Migraine: Predictors of Clinical Improvement Following PFO Closure Presenter: Brian Whisenant October 22, 2012
Presentation TCT 2012 Making PFO Closure the Lowest Risk Interventional Procedure: Devices and Techniques Presenter: Horst Sievert October 22, 2012
Presentation TCT 2012 Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? NO Presenter: John Carroll October 22, 2012
Presentation TCT 2012 Debate: Should ASD Closure Only be Done in SHD/CHD Centers of Excellence? YES Presenter: Ted Feldman October 22, 2012
Presentation TCT 2012 ASD Closure: The European Perspectives Presenter: Horst Sievert October 22, 2012
Presentation TCT 2012 ASD Closure: Current Techniques, Avoiding Erosion, and the Role of Surgery Presenter: Ziyad Hijazi October 22, 2012
News Industry News FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study October 22, 2012
News Industry News First Patient Enrolled in GORE® Septal Occluder Clinical Study for Atrial Septal Defect October 19, 2012